Vascular Closure Device Seals Percutaneous Entry Point

During the procedure, a proprietary biocompatible stainless steel implant--which is radiopaque and visible under fluoroscopic control during all phases of deployment and implantation--is applied to both the inside and the outside of the puncture site in the femoral artery at the level of the arterial wall.

Celt ACD is available pre-mounted to a 5F, 6F, or 7F delivery system, and does not require the user to exchange the existing procedural sheath before deployment. The device is contraindicated in patients with a femoral artery lumen diameter less than 5mm, patients with a known allergy to stainless steel, in severe, acute non-cardiac systemic disease or terminal illness with a life expectancy of less than one year, and in patients with systemic bacterial or cutaneous infection, active hematoma, arteriovenous fistula (AVF), pseudoaneurysm, or low platelet count.

“Celt ACD has proven itself to be a best in class arterial puncture closure device. The device allows immediate closure of multiple re-sticks in calcified vessels, and is also very comfortable for patients,” said Jim Coleman MD, co-founder, CEO, and clinical director of Vasorum, adding, “the device allows rapid and complete hemostasis independent of vascular anatomy, including calcified arteries.”

Vascular complications related to arterial access are common causes of morbidity, mortality, and cost in those undergoing PCI. Many strategies have been tried to decrease bleeding and vascular access site complications; vascular closure devices emerged as an effective alternative to traditional mechanical compression, as they can reduce time to hemostasis, facilitate early patient mobilization, reduce patient discomfort associated with prolonged bed rest, improve patient satisfaction, and reduce hospital length of stay.

Related Links:
Vasorum